Exact Mass: 440.98235020000004

Exact Mass Matches: 440.98235020000004

Found 21 metabolites which its exact mass value is equals to given mass value 440.98235020000004, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

   
   

sodium 4-(4-bromophenyl)-2-(4-fluorobenzamido)thiophene-3-carboxylate

sodium 4-(4-bromophenyl)-2-(4-fluorobenzamido)thiophene-3-carboxylate

C18H10BrFNNaO3S (440.9446462000001)


   

[(η2-1,2-Ethynediyl)bis[trimethylsilane]](1,1,1,5,5,5-hexafluoro-2,4-pentanedionato-O,O′) copper

[(η2-1,2-Ethynediyl)bis[trimethylsilane]](1,1,1,5,5,5-hexafluoro-2,4-pentanedionato-O,O′) copper

C13H20CuF6O2Si2 (441.0201962)


   

Brimonidine tartrate

Brimonidine L-tartrate

C15H16BrN5O6 (441.0283896)


C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents Brimonidine tartrate (UK 14304 tartrate) is a full α2-adrenergic receptor (α2-AR) agonist.

   

N-{3-[(2-chloro-4-pyrimidinyl)acetyl]-2-fluorophenyl}-2,6-difluorobenzenesulfonamide

N-{3-[(2-chloro-4-pyrimidinyl)acetyl]-2-fluorophenyl}-2,6-difluorobenzenesulfonamide

C18H11ClF3N3O3S (441.0161722)


   

sn-Glycero-3-phosphocholine 1:1 cadmium chloride adduct

sn-Glycero-3-phosphocholine 1:1 cadmium chloride adduct

C8H20CdCl2NO6P (440.9438860000001)


   
   

7-(4-Chlorophenyl)-2-[[3-chloro-5-(trifluoromethyl)-2-pyridinyl]thio]-[1,2,4]triazolo[1,5-a]pyrimidine

7-(4-Chlorophenyl)-2-[[3-chloro-5-(trifluoromethyl)-2-pyridinyl]thio]-[1,2,4]triazolo[1,5-a]pyrimidine

C17H8Cl2F3N5S (440.98295440000004)


   

6-bromo-8-methoxy-2-oxo-N-[3-(trifluoromethyl)phenyl]chromene-3-carboxamide

6-bromo-8-methoxy-2-oxo-N-[3-(trifluoromethyl)phenyl]chromene-3-carboxamide

C18H11BrF3NO4 (440.98235020000004)


   
   

GDP dianion

GDP dianion

C10H13N5O11P2-2 (441.00868080000004)


COVID info from COVID-19 Disease Map Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

   

3-[2-[(E)-2-cyano-2-(4-fluorophenyl)sulfonylethenyl]pyrrol-1-yl]sulfonylbenzonitrile

3-[2-[(E)-2-cyano-2-(4-fluorophenyl)sulfonylethenyl]pyrrol-1-yl]sulfonylbenzonitrile

C20H12FN3O4S2 (441.02532440000004)


   

5-bromo-N-(4,5-dihydro-1H-imidazol-2-yl)quinoxalin-6-amine (2R,3R)-2,3-dihydroxybutanedioic acid

5-bromo-N-(4,5-dihydro-1H-imidazol-2-yl)quinoxalin-6-amine (2R,3R)-2,3-dihydroxybutanedioic acid

C15H16BrN5O6 (441.0283896)


   

5-(3-Bromophenyl)-1-(furan-2-ylmethyl)-4-(5-methylfuran-2-carbonyl)pyrrolidine-2,3-dione

5-(3-Bromophenyl)-1-(furan-2-ylmethyl)-4-(5-methylfuran-2-carbonyl)pyrrolidine-2,3-dione

C21H16BrNO5 (441.02117860000004)


   

XDP(3-)

XDP(3-)

C10H11N4O12P2 (440.98487259999996)


Trianion of xanthosine 5-diphosphate arising from deprotonation of all three OH groups of the diphosphate.

   

GDP(2-)

GDP(2-)

C10H13N5O11P2 (441.00868080000004)


An organophosphate oxoanion arising from deprotonation of two of the the three diphosphate OH groups of guanosine 5-diphosphate.

   

hPL-IN-2

hPL-IN-2

C19H11Cl4NO3 (440.9493016)


hPL-IN-2 (compound 2u) is a potent, reversible, and non-competitive inhibitor of pancreatic lipase (IC50: 1.63 μM) and can be used in anti-obesity research[1].